Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Broad-range test diagnoses Hong Kong avian influenza:

This article was originally published in Clinica

Executive Summary

The ZStatFlu point-of-care test detects H5N1 avian influenza (Hong Kong bird flu) as reliably as it detects other human-infectious influenza A and B varieties, claims its US supplier ZymeTx. The test, which measures internal activity of the influenza viral surface protein neuraminidase, rather than antibodies, was validated on H5N1 isolates at the US Centers for Disease Control, says the Oklahoma City company. ZStatFlu obtained US approval in September as a rapid tool for control of emerging flu epidemics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT080891

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel